FDA Inspection 996030 — Glenmark Pharmaceuticals Inc., USA
The FDA completed an inspection of Glenmark Pharmaceuticals Inc., USA on Dec 5, 2016 in Elmwood Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 5, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Elmwood Park, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)